Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy

NCT00777179 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Vandetanib
DRUG: Placebo

Sponsor

Genzyme, a Sanofi Company